Clinical Trials in New York State

Showing 2381-2400 of 14,718 trials

Novel Delivery Method of Transgender Voice Therapy Using a Mobile Application

NCT05815810

The investigators hypothesize that the mobile application they developed for transgender and gender diverse individuals (TGGD) will be equivalent or better than traditional speech therapy in improving voice quality. The investigators will measure both how the participants feel about their voices and how their voice actually sounds to see if the app is effective.

Transitioning Voice of Transgender and Gender Diverse People

Weill Medical College of Cornell University50 participantsStarted Dec 2026

Ithaca, New York, United States • New York, New York, United States

COMPLETEDPhase 383 miles

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

NCT05093933

The purpose of this study is to evaluate the efficacy and safety of vericiguat in participants with chronic heart failure with reduced ejection fraction (HFrEF), specifically those with symptomatic chronic HFrEF who have not had a recent hospitalization for heart failure or need for outpatient intravenous (IV) diuretics. The primary hypothesis is that vericiguat is superior to placebo in reducing the risk of cardiovascular death or heart failure hospitalization.

Chronic Heart Failure With Reduced Ejection Fraction

Merck Sharp & Dohme LLC6,106 participantsStarted Nov 2021

Alexander City, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +516 more locations

Novel Delivery Method of Transgender Voice Therapy Using a Mobile Application

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

Find Trials by Condition in New York State

Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria

A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Pancreatic Cancer Detection Consortium

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy

C.Difficile Observational Study

Spine Oncology Registry

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age

Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

Evaluating The Safety and Effectiveness of The NeoDisc™ Versus ACDF in Subjects With Single-Level Cervical Disc Disease

Combined Cortical/Subcortical Recording and Stimulation as a Circuit-Oriented Treatment for Obsessive-Compulsive Disorder

A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Validating Innovative Biosensors for Rett Autonomic Symptom Tracking

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System